GFAP and Alzheimer disease: Similar to in LOAD, in adults with DS, plasma levels of glial fibrillary acidic protein (GFAP), a marker of reactive astrocytosis, differentiate between those with and without AD dementia, correlating strongly with Aβ pathology, neurodegeneration, and AD clinical progression.92